Insider Ledger
JAZZ insider buying and SEC filings, explained
Jazz Pharmaceuticals plc · CIK 1232524
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- L2
- Fiscal year end
- Dec 31
- Former names
- JAZZ PHARMACEUTICALS INC
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$6.8M
Planned sales (10b5-1)
$33.2M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 6, 2026 | Planned (10b5-1) | Renee D. Gala (CEO and Director) sold 2,000 shares at $236.40 ($473K), marked as a 10b5-1 plan trade. Holdings down 1% to 141,394 shares. | SEC filing Filed Oct 7, 2026, 5:44 PM ET |
| Oct 1, 2026 | Planned (10b5-1) | Bruce C. Cozadd (Director) sold 6,000 shares at $230.33 ($1.4M), marked as a 10b5-1 plan trade. Holdings down 2% to 345,875 shares. | SEC filing Filed Oct 5, 2026, 4:18 PM ET |
| Sep 10, 2026 | Planned (10b5-1) | Neena M Patil (EVP & Chief Legal Officer) sold 1,200 shares at $240.94 ($289K), marked as a 10b5-1 plan trade. Holdings down 2% to 47,671 shares. | SEC filing Filed Sep 14, 2026 |
| Sep 8, 2026 | Planned (10b5-1) | Renee D. Gala (CEO) sold 2,000 shares at $243.03 ($486K), marked as a 10b5-1 plan trade. Holdings down 1% to 143,394 shares. | SEC filing Filed Sep 10, 2026 |
| Sep 1, 2026 | Planned (10b5-1) | Bruce C. Cozadd (Director) sold 6,000 shares at $250.13 ($1.5M), marked as a 10b5-1 plan trade. Holdings down 2% to 351,875 shares. | SEC filing Filed Sep 2, 2026 |
| Aug 27, 2026 | Planned (10b5-1) | Robert Iannone (EVP, Global Head of R&D & CMO) sold 76,921 shares at about $249.70 ($19.2M), marked as a 10b5-1 plan trade. Holdings down 54% to 65,686 shares. | SEC filing Filed Aug 31, 2026 |
| Aug 3, 2026 | Planned (10b5-1) | Bruce C. Cozadd (Director) sold 6,000 shares at $252.98 ($1.5M), marked as a 10b5-1 plan trade. Holdings down 2% to 360,682 shares. | SEC filing Filed Aug 5, 2026 |
| Jul 1, 2026 | Planned (10b5-1) | Bruce C. Cozadd (Director) sold 6,000 shares at $240.47 ($1.4M), marked as a 10b5-1 plan trade. Holdings down 2% to 366,682 shares. | SEC filing Filed Jul 6, 2026 |
| Jun 15, 2026 | Planned (10b5-1) | Mark Douglas Smith (Director) sold 1,157 shares at $230.55 ($267K), marked as a 10b5-1 plan trade. Holdings down 11% to 9,680 shares. | SEC filing Filed Jun 17, 2026 |
| Jun 10, 2026 | Planned (10b5-1) | Neena M Patil (EVP & Chief Legal Officer) sold 1,200 shares at $231.83 ($278K), marked as a 10b5-1 plan trade. Holdings down 2% to 51,549 shares. | SEC filing Filed Jun 12, 2026 |
| Jun 1, 2026 | Planned (10b5-1) | Bruce C. Cozadd (Director) sold 6,000 shares at $235.12 ($1.4M), marked as a 10b5-1 plan trade. Holdings down 2% to 372,682 shares. | SEC filing Filed Jun 3, 2026 |
| May 28, 2026 | Planned (10b5-1) | Neena M Patil (EVP & Chief Legal Officer) sold 1,192 shares at $236.97 ($282K), marked as a 10b5-1 plan trade. Holdings down 2% to 52,626 shares. | SEC filing Filed Jun 1, 2026 |
| May 22, 2026 | Sale | Heather Ann McSharry (Director) sold 2,000 shares at $241.00 ($482K). Holdings down 10% to 18,449 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 27, 2026 |
| May 1, 2026 | Planned (10b5-1) | Bruce C. Cozadd (Director) sold 6,000 shares at $203.33 ($1.2M), marked as a 10b5-1 plan trade. Holdings down 2% to 378,682 shares. | SEC filing Filed May 5, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | Bruce C. Cozadd (Director) sold 6,000 shares at about $190.50 ($1.1M), marked as a 10b5-1 plan trade. Holdings down 2% to 384,682 shares. | SEC filing Filed Apr 3, 2026 |
| Mar 9, 2026 | Sale | Patricia Carr (SVP, Chief Accounting Officer) sold 1,287 shares at $182.94 ($235K). Holdings down 17% to 6,512 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 9, 2026 |
| Mar 3, 2026 | Planned (10b5-1) | Bruce C. Cozadd (Director) sold 6,000 shares at about $186.44 ($1.1M), marked as a 10b5-1 plan trade. Holdings down 1% to 405,796 shares. | SEC filing Filed Mar 4, 2026 |
| Feb 26, 2026 | Sale | Mary Elizabeth Henderson (SVP, Technical Operations) sold 5,343 shares at about $194.49 ($1.0M). Holdings down 16% to 28,728 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 2, 2026 |
| Feb 26–27, 2026 | Sale | Patricia Carr (SVP, Chief Accounting Officer) sold 2,370 shares between Feb 26 and Feb 27 at about $192.60 ($456K). Holdings down 20% to 9,235 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 2, 2026 |
| Dec 9, 2025 | Sale | Mary Elizabeth Henderson (SVP, Technical Operations) sold 2,238 shares at about $169.51 ($379K). Holdings down 10% to 19,508 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 11, 2025 |
| Nov 18, 2025 | Sale | Rick E Winningham (Director) sold 5,500 shares at $180.86 ($995K). Holdings down 38% to 8,893 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 20, 2025 |
| Nov 18, 2025 | Sale | Bruce C. Cozadd (Director) sold 18,000 shares at about $181.09 ($3.3M). Holdings down 4% to 390,826 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 20, 2025 |
| Nov 17, 2025 | Planned (10b5-1) | Robert Iannone (EVP, Global Head of R&D & CMO) sold 7,159 shares at $168.26 ($1.2M), marked as a 10b5-1 plan trade. Holdings down 9% to 72,628 shares. | SEC filing Filed Nov 19, 2025 |
76 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 2, 2026, 4:07 PM ET 8-K | Earnings released (Item 2.02) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow JAZZ in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.